Lovenox Discontinued Promotions Are “False,” But Corrective Ads Not Warranted – Court
This article was originally published in The Pink Sheet Daily
Executive Summary
Aventis’ claims that enoxaparin is “therapeutic from dose one” and “reaches therapeutic levels within ½ hour” are unsupported. However, the claim that Lovenox requires “no routine monitoring” is not literally false, the court says.